Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
mi
from
Roseville, CA
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
mi
from
Roseville, CA
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
mi
from
Miami, FL
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
mi
from
Eagle, ID
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
mi
from
Eagle, ID
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
mi
from
Normal, IL
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
mi
from
Normal, IL
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
mi
from
Gaithersburg, MD
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
mi
from
Gaithersburg, MD
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
mi
from
North Dartmouth, MA
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
mi
from
Teaneck, NJ
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
mi
from
Canton, OH
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
mi
from
Canton, OH
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
mi
from
Collegeville, PA
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
mi
from
Collegeville, PA
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
mi
from
Warwick, RI
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated:  12/18/2013
Clinical Research Facility
mi
from
Murray, UT
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast
Status: Enrolling
Updated: 12/18/2013
Clinical Research Facility
mi
from
Murray, UT
Click here to add this to my saved trials
Transporter Mediated Uptake of Montelukast
Characterization of Transporter Mediated Uptake of Montelukast in Humans
Status: Enrolling
Updated:  1/23/2014
Nemours Children's Clinic
mi
from
Jacksonville, FL
Transporter Mediated Uptake of Montelukast
Characterization of Transporter Mediated Uptake of Montelukast in Humans
Status: Enrolling
Updated: 1/23/2014
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Genotype Stratified Pharmacokinetic Study of Montelukast
Genotype Stratified Pharmacokinetic Study of Montelukast
Status: Enrolling
Updated:  1/23/2014
Nemours Children's Clinic
mi
from
Jacksonville, FL
Genotype Stratified Pharmacokinetic Study of Montelukast
Genotype Stratified Pharmacokinetic Study of Montelukast
Status: Enrolling
Updated: 1/23/2014
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated:  1/27/2014
Novartis Investigative Site
mi
from
Anaheim, CA
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated: 1/27/2014
Novartis Investigative Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated:  1/27/2014
Novartis Investigative Site
mi
from
Aventura, FL
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated: 1/27/2014
Novartis Investigative Site
mi
from
Aventura, FL
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated:  1/27/2014
Novartis Investigative site
mi
from
Boston, MA
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated: 1/27/2014
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated:  1/27/2014
Novartis Investigative Site
mi
from
Raleigh, NC
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated: 1/27/2014
Novartis Investigative Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated:  1/27/2014
Novartis Investigative Site
mi
from
Winston-Salem, NC
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated: 1/27/2014
Novartis Investigative Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated:  1/27/2014
Novartis Investigative Site
mi
from
Spartanburg, SC
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.
Status: Enrolling
Updated: 1/27/2014
Novartis Investigative Site
mi
from
Spartanburg, SC
Click here to add this to my saved trials
CYT003 in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids
A Randomized, Placebo-Controlled, Phase IIb Study of CYT003-QbG10 (CYT003), a TLR9 Agonist, in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids
Status: Enrolling
Updated:  3/12/2014
University of South Florida
mi
from
Tampa, FL
CYT003 in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids
A Randomized, Placebo-Controlled, Phase IIb Study of CYT003-QbG10 (CYT003), a TLR9 Agonist, in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids
Status: Enrolling
Updated: 3/12/2014
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Sub-Sensitivity to Long-Acting Bronchodilators (LABA)
Sub-Sensitivity to Long-Acting Bronchodilators (LABA)
Status: Enrolling
Updated:  3/13/2014
National Jewish Health
mi
from
Denver, CO
Sub-Sensitivity to Long-Acting Bronchodilators (LABA)
Sub-Sensitivity to Long-Acting Bronchodilators (LABA)
Status: Enrolling
Updated: 3/13/2014
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use
Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use
Status: Enrolling
Updated:  4/21/2014
Arkansas Children's Hospital
mi
from
Little Rock, AR
Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use
Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use
Status: Enrolling
Updated: 4/21/2014
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Little Rock, AR
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Costa Mesa, CA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Huntington Beach, CA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Long Beach, CA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Newport Beach, CA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Orange, CA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Rolling Hills Estates, CA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Aventura, FL
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Aventura, FL
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Cocoa, FL
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Cocoa, FL
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Miami, FL
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Columbus, GA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Columbus, GA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Eagle, ID
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Eagle, ID
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Normal, IL
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Normal, IL
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Shiloh, IL
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Shiloh, IL
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Lenexa, KA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Owensboro, KY
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Owensboro, KY
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Stevensville, MI
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Stevensville, MI
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Plymouth, MN
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Plymouth, MN
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Columbia, MO
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Columbia, MO
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Rolla, MO
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Rolla, MO
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Corning, NY
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Corning, NY
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Raleigh, NC
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Canton, OH
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Canton, OH
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Cincinnati, OH
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Oklahoma City, OK
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Medford, OR
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Portland, OR
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Pittsburgh, PA
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials